KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Inventory (2016 - 2025)

Merck (MRK) has disclosed Inventory for 17 consecutive years, with $6.7 billion as the latest value for Q4 2025.

  • Quarterly Inventory rose 8.99% to $6.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.7 billion through Dec 2025, up 8.99% year-over-year, with the annual reading at $6.7 billion for FY2025, 8.99% up from the prior year.
  • Inventory for Q4 2025 was $6.7 billion at Merck, up from $6.4 billion in the prior quarter.
  • The five-year high for Inventory was $6.7 billion in Q4 2025, with the low at $5.5 billion in Q2 2021.
  • Average Inventory over 5 years is $6.1 billion, with a median of $6.1 billion recorded in 2023.
  • The sharpest move saw Inventory dropped 9.81% in 2022, then increased 11.04% in 2024.
  • Over 5 years, Inventory stood at $6.0 billion in 2021, then decreased by 0.71% to $5.9 billion in 2022, then grew by 7.56% to $6.4 billion in 2023, then decreased by 3.92% to $6.1 billion in 2024, then rose by 8.99% to $6.7 billion in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $6.7 billion, $6.4 billion, and $6.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.